Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy

American Journal of Cardiology

Volumn 116, Issue 3, 2015, Pages 442-446

  Wang, Lin ^a   Tan, Timothy C ^a   Halpern, Elkan F ^a   Neilan, Tomas G ^b   Francis, Sanjeev A ^b   Picard, Michael H ^a   Fei, Hongwen ^a   Hochberg, Ephraim P ^a   Abramson, Jeremy S ^a   Weyman, Arthur E ^a   Kuter, Irene ^a   Scherrer Crosbie, Marielle ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IDARUBICIN; ANTHRACYCLINE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LEFT VETRICULAR DIMENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENESCENCE; SEX DIFFERENCE; SURVIVAL TIME; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; DRUG EFFECTS; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; MIDDLE AGED; NEOPLASMS; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

ANTHRACYCLINES; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84937526266     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.04.064     Document Type: Article

References (14)

1. D.D. Hoff Von, M.W. Layard, P. Basa, H.L. Davis, A.L. Hoff Von, M. Rozencweig, and F.M. Muggia Risk factors for doxorubicin-induced congestive heart failure Ann Intern Med 91 1979 710 717
2. S.M. Swain, F.S. Whaley, and M.S. Ewer Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2003 2869 2879
3. J. Alexander, N. Dainiak, H.J. Berger, L. Goldman, D. Johnstone, L. Reduto, T. Duffy, P. Schwartz, A. Gottschalk, and B.L. Zaret Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography N Engl J Med 300 1979 278 283
4. R.G. Schwartz, W.B. McKenzie, J. Alexander, P. Sager, A. D'Souza, A. Manatunga, P.E. Schwartz, H.J. Berger, J. Setaro, and L. Surkin Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography Am J Med 82 1987 1109 1118
5. A.L. Conrad, J.D. Gundrum, V.L. McHugh, and R.S. Go Utility of routine left ventricular ejection fraction measurement before anthracycline-based chemotherapy in patients with diffuse large B-cell lymphoma J Oncol Pract 8 2012 336 340
6. R.G. Watts, M. George, and W.H. Johnson Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: a 5-year review at a single pediatric oncology center Cancer 118 2012 1919 1924
7. A.E. Weyman Left ventricle I:general considerations, assessment of chamber size and function Principles and Practice of Echocardiography 2nd ed. 1994 Lippincott Williams & Wilkins Philadelphia 606
8. R.M. Lang, L.P. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande, F.A. Flachskampf, E. Foster, S.A. Goldstein, T. Kuznetsova, P. Lancellotti, D. Muraru, M.H. Picard, E.R. Rietzschel, L. Rudski, K.T. Spencer, W. Tsang, and J.U. Voigt Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging J Am Soc Echocardiogr 28 2015 1 39
9. E.H. Romond, J.-H. Jeong, P. Rastogi, S.M. Swain, C.E. Geyer, M.S. Ewer, V. Rathi, L. Fehrenbacher, A. Brufsky, C.A. Azar, P.J. Flynn, J.L. Zapas, J. Polikoff, H.M. Gross, D.D. Biggs, J.N. Atkins, E. Tan-Chiu, P. Zheng, G. Yothers, E.P. Mamounas, and N. Wolmark Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer J Clin Oncol 30 2012 3792 3799
10. S. Limat, K. Demesmay, L. Voillat, Y. Bernard, E. Deconinck, A. Brion, A. Sabbah, M.C. Woronoff-Lemsi, and J.Y. Cahn Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma Ann Oncol 14 2003 277 281
11. O. Hequet, Q.H. Le, I. Moullet, E. Pauli, G. Salles, D. Espinouse, C. Dumontet, C. Thieblemont, P. Arnaud, D. Antal, F. Bouafia, and B. Coiffier Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults J Clin Oncol 22 2004 1864 1871
12. M. Procter, T.M. Suter, E. de Azambuja, U. Dafni, V. van Dooren, S. Muehlbauer, M.A. Climent, E. Rechberger, W.T. Liu, M. Toi, R.C. Coombes, D. Dodwell, O. Pagani, J. Madrid, M. Hall, S.-C. Chen, C. Focan, M. Muschol, D.J. van Veldhuisen, and M.J. Piccart-Gebhart Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial J Clin Oncol 28 2010 3422 3428
13. L.R. Goldberg, and M. Jessup Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction Circulation 113 2006 2851 2860
14. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, G. De Giacomi, M. Rubino, F. Veglia, C. Fiorentini, and C.M. Cipolla Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220